HMGB1 and Sepsis: By enhancing the SIRT1-mediated deacetylation of HMGB1, CGK012 may mitigate the damaging effects of HMGB1 on the vascular barrier, highlighting its therapeutic potential in pathological vascular inflammation associated with conditions such as sepsis.